share_log

Assertio to Present at LD Micro Invitational Conference in New York City

Assertio to Present at LD Micro Invitational Conference in New York City

Assertio 將出席在紐約市舉行的 LD Micro 邀請會議
GlobeNewswire ·  04/01 09:00

LAKE FOREST, Ill., April 01, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that Ajay Patel, Chief Financial Officer, will present at the LD Micro Invitational XIV Conference to be held April 9, 2024 in New York City.

伊利諾伊州森林湖,2024年4月1日(環球新聞專線)——具有爲患者提供差異化產品的全面商業能力的製藥公司Assertio Holdings, Inc.(“Assertio” 或 “公司”)(納斯達克股票代碼:ASRT)今天宣佈,首席財務官阿賈伊·帕特爾將出席將於2024年4月9日在紐約市舉行的第十四屆LD Micro邀請賽。

The Company will host a group presentation at 4:00 pm Eastern Time, and be available for individual meetings throughout the day. Attending investors interested in meeting with the Company can request a meeting on the conference platform, or contact Assertio investor relations via mkreps@darrowir.com.

公司將在美國東部時間下午 4:00 舉辦小組演講,並全天候提供個人會議。有興趣與公司會面的與會投資者可以申請在會議平台上開會,也可以通過 mkreps@darrowir.com 聯繫Assertio投資者關係部。

Presentation information will be available on the day of the event and can accessed at To listen to the presentation webcast, please connect to the website link at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed.

演示信息將在活動當天提供,可通過以下網址進行訪問。要收聽演示網絡直播,請在網絡直播前至少 15 分鐘連接到網站鏈接,以確保有足夠的時間下載可能需要的任何軟件。

About Assertio

關於 Assertio

Assertio is a commercial pharmaceutical company offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit .

Assertio是一家商業製藥公司,爲患者提供差異化產品。我們通過收購或許可經批准的產品來建立我們的商業投資組合。我們全面的商業能力包括通過銷售隊伍和非個人促銷模式進行營銷、通過付款人合同獲得市場準入以及貿易和分銷。要了解有關 Assertio 的更多信息,請訪問 。

Forward Looking Statements

前瞻性陳述

Statements in this communication that are not historical facts are forward-looking statements that reflect Assertio's current expectations, assumptions and estimates of future performance and economic conditions. These forward-looking statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, future events or the future performance or operations of Assertio, including risks related to our ability to realize the benefits from our operating model, successfully integrate new assets, explore new business development initiatives, and successfully recruit a successor CEO on a timely basis. All statements other than historical facts may be forward-looking statements and can be identified by words such as "anticipate," "believe," "could," "design," "estimate," "expect," "forecast," "goal," "guidance," "imply," "intend," "may," "objective," "opportunity," "outlook," "plan," "position," "potential," "predict," "project," "prospective," "pursue," "seek," "should," "strategy," "target," "would," "will," "aim" or other similar expressions that convey the uncertainty of future events or outcomes and are used to identify forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the control of Assertio, including the risks described in Assertio's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the U.S. Securities and Exchange Commission ("SEC") and in other filings Assertio makes with the SEC from time to time. Investors and potential investors are urged not to place undue reliance on forward-looking statements in this communication, which speak only as of this date. While Assertio may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to update or revise any forward-looking-statements contained in this press release whether as a result of new information or future events, except as may be required by applicable law.

本通報中非歷史事實的陳述是前瞻性陳述,反映了Assertio當前對未來業績和經濟狀況的預期、假設和估計。這些前瞻性陳述是根據經修訂的1933年《證券法》第27A條和經修訂的1934年《證券交易法》第21E條的安全港條款作出的。除其他外,這些前瞻性陳述涉及未來事件或Assertio的未來業績或運營,包括與我們從運營模式中獲益、成功整合新資產、探索新業務發展計劃以及成功及時招聘繼任首席執行官的能力相關的風險。除歷史事實以外的所有陳述可能是前瞻性陳述,可以通過 “預測”、“相信”、“可以”、“設計”、“估計”、“預期”、“預測”、“目標”、“指導”、“暗示”、“打算”、“可能”、“目標”、“機會”、“展望”、“計劃”、“立場”、“潛力”、“預測”、“預測”、“” 等詞語來識別項目”、“前瞻性”、“追求”、“尋求”、“應該”、“戰略”、“目標”、“將”、“將”、“目標” 或其他傳達未來事件或結果不確定性並用於識別前瞻性陳述的類似表述。此類前瞻性陳述不能保證未來的表現,並受風險、不確定性和其他因素的影響,其中一些因素是Assertio無法控制的,包括Assertio向美國證券交易委員會(“SEC”)提交的10-K表年度報告和10-Q表季度報告以及Assertio不時向美國證券交易委員會提交的其他文件中描述的風險。敦促投資者和潛在投資者不要過分依賴本通報中的前瞻性陳述,這些陳述僅涉及截至該日期。儘管Assertio可能會選擇在未來的某個時候更新這些前瞻性陳述,但除非適用法律可能要求,否則它明確表示沒有義務更新或修改本新聞稿中包含的任何前瞻性陳述,無論是由於新信息還是未來事件。

Investor Contact

投資者聯繫人

Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com

馬特·克雷普斯,董事總經理
達羅合夥人
M: 214-597-8200
mkreps@darrowir.com


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論